MAT | Mattel Inc

CUSIP: 577081102

1 Funds Holding

12.3M Total Shares

$171M Total Value

$14.92
Price

$4.3B

Market Cap

11.1

P/E Ratio

9.4

Forward P/E

$1.34

EPS (TTM)

—

Dividend Yield

$524M

Cash

$2.7B

Total Debt

286M

Shares Out

$12.73

$22.48

52-Week Range

Fund / Manager Click to search	Shares	Value	% of Portfolio	Cost Basis	Est. Return
Longleaf Partners\|Mason Hawkins	12.3M	$171M	8.92%	—	—

Quarter:

Fund / Manager Click to search	Action	Change	Shares After	Value	Price
2026-Q2
Longleaf Partners	SELL	-3.8%	12.3M	$171M	$14.72
2026-Q1
Longleaf Partners	SELL	-0.3%	12.8M	$186M	$17.34
Patient Capital Management	SELL	EXIT	—	—	$17.34
2025-Q4
Longleaf Partners	BUY	+5.0%	8.6M	$170M	$19.18
Patient Capital Management	BUY	+33.1%	2.8M	$55M	$19.18
2025-Q3
Longleaf Partners	BUY	+13.0%	8.2M	$137M	$18.00
Patient Capital Management	BUY	+43.4%	2.1M	$35M	$18.00
2025-Q2
Longleaf Partners	BUY	+5.6%	7.2M	$142M	$18.80
Patient Capital Management	SELL	-36.6%	1.5M	$29M	$18.80
2025-Q1
Longleaf Partners	SELL	-10.4%	6.8M	$133M	$19.96
Patient Capital Management	SELL	-8.7%	2.3M	$45M	$19.96
2024-Q4
Longleaf Partners	SELL	-4.5%	7.6M	$135M	$18.92
Patient Capital Management	SELL	-0.2%	2.5M	$45M	$18.92
2024-Q3
Longleaf Partners	SELL	-2.7%	8.0M	$152M	$18.93
Patient Capital Management	SELL	-1.1%	2.5M	$48M	$18.93
2024-Q2
Longleaf Partners	SELL	-3.9%	8.2M	$133M	$18.17
Patient Capital Management	SELL	-19.0%	2.6M	$42M	$18.17
2024-Q1
Longleaf Partners	SELL	-3.4%	8.5M	$169M	$19.17
Patient Capital Management	SELL	-3.7%	3.2M	$63M	$19.17
2023-Q4
Longleaf Partners	SELL	-1.7%	8.8M	$167M	$19.10
Patient Capital Management	SELL	-6.6%	3.3M	$62M	$19.10
2023-Q3
Longleaf Partners	SELL	-3.5%	9.0M	$198M	$21.40
Patient Capital Management	SELL	-3.5%	3.5M	$78M	$21.40
2023-Q2
Longleaf Partners	SELL	-17.2%	9.3M	$182M	$18.04
Patient Capital Management	BUY	+722.8%	3.6M	$71M	$18.04
Miller Value Partners	SELL	EXIT	—	—	$18.04
2023-Q1
Longleaf Partners	SELL	-6.4%	11.3M	$207M	$18.44
Miller Value Partners	SELL	-2.6%	3.3M	$60M	$18.44
Patient Capital Management	BUY	+4.2%	443.5K	$8M	$18.44
2022-Q4
Longleaf Partners	SELL	-13.5%	12.0M	$215M	$17.88
Miller Value Partners	SELL	-8.2%	3.4M	$60M	$17.88
Patient Capital Management	SELL	-1.8%	425.5K	$8M	$17.88
2022-Q3
Longleaf Partners	SELL	-13.8%	13.9M	$263M	$22.59
Miller Value Partners	SELL	-0.9%	3.7M	$69M	$22.59
Patient Capital Management	SELL	-7.2%	433.3K	$8M	$22.59
2022-Q2
Longleaf Partners	SELL	-0.2%	16.1M	$360M	$23.25
Miller Value Partners	SELL	-8.6%	3.7M	$82M	$23.25
Patient Capital Management	BUY	+9.4%	467.0K	$10M	$23.25
2022-Q1
Longleaf Partners	SELL	-20.1%	16.2M	$359M	$22.82
Miller Value Partners	BUY	+0.6%	4.0M	$90M	$22.82
Patient Capital Management	BUY	+5.8%	427.0K	$9M	$22.82
2021-Q4
Longleaf Partners	BUY	+10.2%	20.2M	$436M	$21.17
Miller Value Partners	BUY	NEW	4.0M	$87M	$21.17
2021-Q3
Longleaf Partners	SELL	-3.4%	18.3M	$341M	$20.58
2021-Q2
Longleaf Partners	BUY	+17.6%	19.0M	$382M	$20.57
2021-Q1
Longleaf Partners	SELL	-7.3%	16.1M	$322M	$19.04
2020-Q4
Longleaf Partners	SELL	-38.0%	17.4M	$304M	$14.34
2020-Q3
Longleaf Partners	SELL	-3.7%	28.1M	$329M	$11.23
2020-Q2
Longleaf Partners	SELL	-0.9%	29.2M	$282M	$8.95
2020-Q1
Longleaf Partners	SELL	-10.2%	29.4M	$259M	$13.30
2019-Q4
Longleaf Partners	SELL	-3.4%	32.8M	$444M	$11.74
2019-Q3
Longleaf Partners	SELL	-2.1%	33.9M	$387M	$11.41
2019-Q2
Longleaf Partners	SELL	-3.3%	34.7M	$388M	$11.47
2019-Q1
Longleaf Partners	SELL	-10.1%	35.8M	$466M	$13.28
2018-Q4
Longleaf Partners	BUY	+7.5%	39.8M	$398M	$13.69
2018-Q3
Longleaf Partners	BUY	+0.2%	37.0M	$582M	$15.94
2018-Q2
Longleaf Partners	SELL	-0.8%	37.0M	$607M	$14.95
2018-Q1
Longleaf Partners	SELL	-2.6%	37.3M	$490M	$15.98
Gardner Russo & Quinn	SELL	EXIT	—	—	$15.98

No Insider Transactions

No Form 4 filings found for this stock in the last 2 years.